Advertisement

Topics

SwitchGear Genomics, Inc. Company Profile

20:36 EST 18th December 2018 | BioPortfolio

SwitchGear Genomics Inc. is a leading provider of technologically innovative products for studying the regulatory elements in the human genome. The company has developed a comprehensive approach to generate new insights into gene regulatory network, allowing researchers to efficiently screen entire pathways in living cells. SwitchGear was founded in March 2005 by Dr. Richard Myers, Dr. Nathan Trinklein and Dr. Shelley Force Aldred from Stanford University. For more information about SwitchGear, please visit the company’s website at www.switchgeargenomics.com


News Articles [413 Associated News Articles listed on BioPortfolio]

Qatar Switchgear Market, Competition Forecast Opportunities, 2025 - High Investments in ...

DUBLIN, Oct. 1, 2018 /PRNewswire/ -- The "Qatar Switchgear Market By Type (Low Voltage, Medium Voltage, and High Voltage), By End User (Utilities, Residential, Commercial, Read more...

Paralleling Switchgear Market by EndUser Industrial, Commercial, Application Prime, Standby and Peak shave, Transition Type Open Transition and Closed Transition, Voltage Low Voltage and Medium Voltage, and Region Global Forecast to 2023 [Report Updated:

The paralleling switchgear market is projected to grow at a CAGR of 5.82% from 2018 to 2023. The paralleling switchgear market is projected to grow from an estimated USD 1.17 billion in 2018 to USD 1....

M&As this week: 10x Genomics, Atlantic Research Group, AGC

10x Genomics has acquired Spatial Transcriptomics to enter the field of spatial genomics. The acquisition will enable 10x Genomics to gain...Read More... The post M&As this week: 10x Genomics, A...

10X Genomics Prepares to Hire 200 New Employees, Move into Larger Facility

Bay Area-based genomics company 10X Genomics has become one of the fastest growing privately-held companies in the region with an earnings increase of more than 2,000 percent over a three-year period.

Microsoft Genomics Ventures into the Microbiome With Eagle Genomics

LONDON, October 15, 2018 /PRNewswire/ -- Cambridge technology innovators partner with Microsoft Genomics Microbiomic research into immune disorders and antibiotic resistance First microbiome partn...

Festival of Genomics London 2018: the landmark event making genomics mainstream

London, UK, 5th January 2018 / Sciad Newswire / This January sees the third edition of Festival of Genomics London, the largest meeting of its kind in the UK. Following two US editions of the event ...

QUANTUM GENOMICS: Quantum Genomics receives ethics committee approval to initiate clinical study of extended-release firibastat tablets

Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), biopharmaceutical company specializing in the development of a new drug class that directly targets the brain to treat hypertension and h...

Festival of Genomics returns to London to help shape the future of precision medicine

London, UK, 17th December 2018 / Sciad Newswire / In January, the largest genomics event in the UK will return to London for the fourth time. The Festival of Genomics will be held in the Business ...

Drugs and Medications [0 Results]

None

PubMed Articles [207 Associated PubMed Articles listed on BioPortfolio]

Utilization of Genomics and Functional Genomics to Inform Clinical Decisions in IR.

Single-cell genomics.

Current Social Media Conversations about Genetics and Genomics in Health: A Twitter-Based Analysis.

The growing availability of genomic information to the public may spur discussion about genetics and genomics on social media. Sites, including Twitter, provide a unique space for the public to access...

Lifestyle Genomics: Addressing the Multifactorial Nature of Personalized Health.

Brain neurotransmitter transporter/receptor genomics and efavirenz central nervous system adverse events.

We characterized associations between central nervous system (CNS) adverse events and brain neurotransmitter transporter/receptor genomics among participants randomized to efavirenz-containing regimen...

Clinical Trials [94 Associated Clinical Trials listed on BioPortfolio]

Electronic Medical Records and Genomics (eMERGE) Phase III

The Electronic Medical Records and Genomics (eMERGE) Network is in its third phase and during this time is enrolling and sequencing 25,000 individuals on a custom sequencing panel of clini...

Genomics and Postoperative Atrial Fibrillation

This research study is done to find out if genetic make up of a person plays a role in complications and recovery after the Coronary Artery Bypass Graft (CABG) operation. As you may be aw...

Microfluidics and Transcriptomics in Post Solid Organ Transplant Patients

The field of genomics is an exciting new field being applied in medicine. Its use in treating some cancers, sepsis and burn patients has been very promising. As knowledge of genomics and a...

High Throughput Drug Sensitivity and Genomics Data in Developing Individualized Treatment in Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia

This pilot clinical trial studies whether using high throughput drug sensitivity and genomics data is feasible in developing individualized treatment in patients with multiple myeloma or p...

GENetic Education Risk Assessment and TEsting Study

The goal of the GENERATE study is to improve genetic testing and cancer prevention in family members of pancreatic cancer patients with identified genetic mutations (inherited changes). Th...

Companies [415 Associated Companies listed on BioPortfolio]

SwitchGear Genomics

At SwitchGear Genomics we are interested in the set of switching and interrupting devices that regulate expression of genes across the human genome.SwitchGear Genomics was founded in March of 2005 by ...

SwitchGear Genomics Inc.

SwitchGear Genomics Inc. is a leading provider of innovative products for studying gene regulation in the human genome. The company has developed a comprehensive approach to gener...

SwitchGear Genomics, Inc.

SwitchGear Genomics Inc. is a leading provider of technologically innovative products for studying the regulatory elements in the human genome. The company has developed a compreh...

Genomics in Business

In 2003 Keygene initiated the first edition of Genomics in Business. It was the first conference to focus on the existing and future applications of genomics in the Agro-Food industry. With participan...

Genomics One Corporation

Genomics One is a fully integrated biotechnology company committed to the creation of shareholder value through innovation in the fields of genomics, proteomics and mono-clonal antibodies. The mission...

More Information about "SwitchGear Genomics, Inc." on BioPortfolio

We have published hundreds of SwitchGear Genomics, Inc. news stories on BioPortfolio along with dozens of SwitchGear Genomics, Inc. Clinical Trials and PubMed Articles about SwitchGear Genomics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of SwitchGear Genomics, Inc. Companies in our database. You can also find out about relevant SwitchGear Genomics, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...


Corporate Database Quicklinks



Searches Linking to this Company Record